279 related articles for article (PubMed ID: 18824953)
1. Differential effects of factor IIa inhibitors on the endogenous thrombin potential.
Beilfuss A; Grandoch M; Wenzel F; Hohlfeld T; Schrör K; Weber AA
Ther Drug Monit; 2008 Dec; 30(6):740-3. PubMed ID: 18824953
[TBL] [Abstract][Full Text] [Related]
2. The respective and combined anticoagulant effects of recombinant human activated protein C, melagatran and heparins using CAT.
Cimenti C; Koestenberger M; Leschnik B; Haidl H; Muntean W
Thromb Res; 2007; 119(3):361-7. PubMed ID: 16712904
[TBL] [Abstract][Full Text] [Related]
3. Thrombin-activated thrombelastography for evaluation of thrombin interaction with thrombin inhibitors.
Taketomi T; Szlam F; Vinten-Johansen J; Levy JH; Tanaka KA
Blood Coagul Fibrinolysis; 2007 Dec; 18(8):761-7. PubMed ID: 17982317
[TBL] [Abstract][Full Text] [Related]
4. The efficiency of anti-activated factor X and anti-activated factor II anticoagulants.
Stief TW
Blood Coagul Fibrinolysis; 2007 Apr; 18(3):265-9. PubMed ID: 17413764
[TBL] [Abstract][Full Text] [Related]
5. Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography.
Tchaikovski SN; van Vliet HA; Thomassen MC; Bertina RM; Rosendaal FR; Sandset PM; Helmerhorst FM; Tans G; Rosing J
Thromb Haemost; 2007 Dec; 98(6):1350-6. PubMed ID: 18064335
[TBL] [Abstract][Full Text] [Related]
6. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
Choi Q; Kim JE; Hyun J; Han KS; Kim HK
Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
[TBL] [Abstract][Full Text] [Related]
7. HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions.
Kretz CA; Cuddy KK; Stafford AR; Fredenburgh JC; Roberts R; Weitz JI
Thromb Haemost; 2010 Jan; 103(1):83-93. PubMed ID: 20062917
[TBL] [Abstract][Full Text] [Related]
8. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.
Duchemin J; Pan-Petesch B; Arnaud B; Blouch MT; Abgrall JF
Thromb Haemost; 2008 Apr; 99(4):767-73. PubMed ID: 18392335
[TBL] [Abstract][Full Text] [Related]
9. Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation.
Warkentin TE; Greinacher A; Craven S; Dewar L; Sheppard JA; Ofosu FA
Thromb Haemost; 2005 Nov; 94(5):958-64. PubMed ID: 16363236
[TBL] [Abstract][Full Text] [Related]
10. Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography.
Devreese K; Peerlinck K; Arnout J; Hoylaerts MF
Thromb Haemost; 2009 Jan; 101(1):185-96. PubMed ID: 19132207
[TBL] [Abstract][Full Text] [Related]
11. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.
Isbister GK; Woods D; Alley S; O'Leary MA; Seldon M; Lincz LF
Toxicon; 2010 Aug; 56(1):75-85. PubMed ID: 20338189
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory effect of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, compared with enoxaparin and r-hirudin on ex vivo thrombin generation in human plasma.
Boström SL; Hansson GF; Sarich TC; Wolzt M
Thromb Res; 2004; 113(1):85-91. PubMed ID: 15081569
[TBL] [Abstract][Full Text] [Related]
13. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis.
Devreese K; Wijns W; Combes I; Van kerckhoven S; Hoylaerts MF
Thromb Haemost; 2007 Sep; 98(3):600-13. PubMed ID: 17849049
[TBL] [Abstract][Full Text] [Related]
14. Age-dependency of thrombin generation measured by means of calibrated automated thrombography (CAT).
Haidl H; Cimenti C; Leschnik B; Zach D; Muntean W
Thromb Haemost; 2006 May; 95(5):772-5. PubMed ID: 16676066
[TBL] [Abstract][Full Text] [Related]
15. The effect of different anticoagulants on thrombin generation.
Petros S; Siegemund T; Siegemund A; Engelmann L
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):131-7. PubMed ID: 16479195
[TBL] [Abstract][Full Text] [Related]
16. The inhibitory effect of recombinant human soluble thrombomodulin on initiation and extension of coagulation--a comparison with other anticoagulants.
Mohri M; Sugimoto E; Sata M; Asano T
Thromb Haemost; 1999 Dec; 82(6):1687-93. PubMed ID: 10613656
[TBL] [Abstract][Full Text] [Related]
17. From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3.
Dönnecke D; Schweinitz A; Stürzebecher A; Steinmetzer P; Schuster M; Stürzebecher U; Nicklisch S; Stürzebecher J; Steinmetzer T
Bioorg Med Chem Lett; 2007 Jun; 17(12):3322-9. PubMed ID: 17462889
[TBL] [Abstract][Full Text] [Related]
18. Exchange transfusion activates coagulation and alters the coagulation profile in newborn infants.
Långström S; Wartiovaara-Kautto U; Andersson S; Heikinheimo M; Petäjä J
Thromb Haemost; 2006 Aug; 96(2):142-8. PubMed ID: 16894456
[TBL] [Abstract][Full Text] [Related]
19. A step change in oral anticoagulation: lack of coagulation monitoring with ximelagatran.
Carlsson SC; Schulman S
Semin Vasc Med; 2005 Aug; 5(3):259-65. PubMed ID: 16123913
[TBL] [Abstract][Full Text] [Related]
20. Thrombin generation in patients after acute deep-vein thrombosis.
ten Cate-Hoek AJ; Dielis AW; Spronk HM; van Oerle R; Hamulyák K; Prins MH; ten Cate H
Thromb Haemost; 2008 Aug; 100(2):240-5. PubMed ID: 18690343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
